Cargando…
Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
American Society of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736278/ https://www.ncbi.nlm.nih.gov/pubmed/34986251 http://dx.doi.org/10.1182/blood.2021014989 |
| _version_ | 1784628433262739456 |
|---|---|
| author | Terpos, Evangelos Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Briasoulis, Alexandros Gumeni, Sentiljana Malandrakis, Panagiotis Papanagnou, Eleni-Dimitra Migkou, Magdalini Kanellias, Nikolaos Kastritis, Efstathios Trougakos, Ioannis P. Dimopoulos, Meletios A. |
| author_facet | Terpos, Evangelos Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Briasoulis, Alexandros Gumeni, Sentiljana Malandrakis, Panagiotis Papanagnou, Eleni-Dimitra Migkou, Magdalini Kanellias, Nikolaos Kastritis, Efstathios Trougakos, Ioannis P. Dimopoulos, Meletios A. |
| author_sort | Terpos, Evangelos |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8736278 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | American Society of Hematology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-87362782022-01-07 Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy Terpos, Evangelos Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Briasoulis, Alexandros Gumeni, Sentiljana Malandrakis, Panagiotis Papanagnou, Eleni-Dimitra Migkou, Magdalini Kanellias, Nikolaos Kastritis, Efstathios Trougakos, Ioannis P. Dimopoulos, Meletios A. Blood Letters to Blood American Society of Hematology 2022-03-03 /pmc/articles/PMC8736278/ /pubmed/34986251 http://dx.doi.org/10.1182/blood.2021014989 Text en © 2022 by The American Society of Hematology |
| spellingShingle | Letters to Blood Terpos, Evangelos Gavriatopoulou, Maria Ntanasis-Stathopoulos, Ioannis Briasoulis, Alexandros Gumeni, Sentiljana Malandrakis, Panagiotis Papanagnou, Eleni-Dimitra Migkou, Magdalini Kanellias, Nikolaos Kastritis, Efstathios Trougakos, Ioannis P. Dimopoulos, Meletios A. Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy |
| title | Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy |
| title_full | Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy |
| title_fullStr | Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy |
| title_full_unstemmed | Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy |
| title_short | Booster BNT162b2 optimizes SARS-CoV-2 humoral response in patients with myeloma: the negative effect of anti-BCMA therapy |
| title_sort | booster bnt162b2 optimizes sars-cov-2 humoral response in patients with myeloma: the negative effect of anti-bcma therapy |
| topic | Letters to Blood |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8736278/ https://www.ncbi.nlm.nih.gov/pubmed/34986251 http://dx.doi.org/10.1182/blood.2021014989 |
| work_keys_str_mv | AT terposevangelos boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT gavriatopouloumaria boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT ntanasisstathopoulosioannis boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT briasoulisalexandros boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT gumenisentiljana boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT malandrakispanagiotis boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT papanagnouelenidimitra boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT migkoumagdalini boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT kanelliasnikolaos boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT kastritisefstathios boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT trougakosioannisp boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy AT dimopoulosmeletiosa boosterbnt162b2optimizessarscov2humoralresponseinpatientswithmyelomathenegativeeffectofantibcmatherapy |